ACCC vs Pfizer case comes to a close

gavel court legal
The High Court has dismissed the ACCC’s application for special leave to appeal in its case against Pfizer Australia over the sale of atorvastatin This month the Australian Competition and Consumer Commission (ACCC) sought leave to appeal against a judgment handed down by the Full Federal Court on 25 May 2018, following a longstanding case

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous A matter of life and death
Next 5 hidden pitfalls in ‘standard’ franchise agreements